In conclusion, our investigation elucidated that that miR-4521 possesses anti-metastatic activity in GC, and this microRNA functions by targeting IGF2 and FOXM1 and inactivating the AKT/GSK3β/Snai1 pathway (Fig. 7h). The gene discussed is FOXM1; the disease is gastric cancer.